H. Humphreys

14.6k total citations
283 papers, 9.4k citations indexed

About

H. Humphreys is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, H. Humphreys has authored 283 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Infectious Diseases, 71 papers in Epidemiology and 55 papers in Clinical Biochemistry. Recurrent topics in H. Humphreys's work include Antimicrobial Resistance in Staphylococcus (85 papers), Bacterial Identification and Susceptibility Testing (55 papers) and Infection Control in Healthcare (52 papers). H. Humphreys is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (85 papers), Bacterial Identification and Susceptibility Testing (55 papers) and Infection Control in Healthcare (52 papers). H. Humphreys collaborates with scholars based in Ireland, United Kingdom and United States. H. Humphreys's co-authors include James P. O’Gara, Eoghan O’Neill, Fidelma Fitzpatrick, Kevin M. Conlon, Deirdre Fitzgerald‐Hughes, D. Ashley Robinson, Clarissa Pozzi, Patrick Houston, Georgina Gethin and E.G. Smyth and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Applied and Environmental Microbiology.

In The Last Decade

H. Humphreys

277 papers receiving 8.9k citations

Peers

Countries citing papers authored by H. Humphreys

Since Specialization

Citations

This map shows the geographic impact of H. Humphreys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Humphreys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Humphreys more than expected).

Fields of papers citing papers by H. Humphreys

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Humphreys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Humphreys. The network helps show where H. Humphreys may publish in the future.

Co-authorship network of co-authors of H. Humphreys

This figure shows the co-authorship network connecting the top 25 collaborators of H. Humphreys. A scholar is included among the top collaborators of H. Humphreys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Humphreys. H. Humphreys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Variability in follow-up strategies for carbapenemase-producing Gram-negative carriers: results from an international scoping survey 2025 ·Journal of Hospital Infection ·Andrea Büchler, Anne F. Voor in ’t holt, H. Humphreys, Juliëtte A. Severin, Martine De Vos	0
2	Rethinking Clostridioides difficile infection (CDI) surveillance definitions based on changing healthcare utilisation and a more realistic incubation period: reviewing data from a tertiary-referral hospital, Ireland, 2012 to 2021 2024 ·Eurosurveillance ·Máiréad Skally, Kathleen Bennett, H. Humphreys, Fidelma Fitzpatrick	2
3	Invasive pneumococcal surveillance to assess the potential benefits of extended spectrum conjugate vaccines (PCV15/PCV20) in older adults 2023 ·Epidemiology and Infection ·H. Humphreys, Mary Corcoran, Jolita Mereckiene, Robert Cunney, Suzanne Cotter	3
4	Greater attention to flexible hospital designs and ventilated clinical facilities are a pre-requisite for coping with the next airborne pandemic 2023 ·Clinical Microbiology and Infection ·H. Humphreys, Martine De Vos, Elisabeth Presterl, Markus Hell	1
5	In situ generation of cold atmospheric plasma-activated mist and its biocidal activity against surrogate viruses for COVID-19 2023 ·Journal of Applied Microbiology ·(unknown), Stephen Daniels, Thomas P. Thompson, Brendan Gilmore, H. Humphreys	11
6	European society of Clinical Microbiology and Infectious Diseases guidelines on diagnosis and treatment of brain abscess in children and adults 2023 ·Clinical Microbiology and Infection ·Jacob Bodilsen, Quintino Giorgio D’Alessandris, H. Humphreys, Mildred A. Iro, Matthias Klein, Katharina Last, Inmaculada López-Montesinos, Pasquale Pagliano, Oğuz Reşat Sıpahı, Rafael San Juan, Pierre Tattevin, Majda M. Thurnher, Rogelio de J. Treviño‐Rangel, Matthijs C. Brouwer	32
7	Reflections on a national public health emergency response to carbapenemase-producing Enterobacterale 2022 ·Research Portal (Queen's University Belfast) ·H. Humphreys, Martin Cormican, (unknown), Karen Burns, Diarmuid O’Donovan, (unknown), (unknown), (unknown)	5
8	Core curriculum in pathology for future Irish medical students 2021 ·Irish Journal of Medical Science (1971 -) ·H. Humphreys, Niall T. Stevens, Louise Burke, (unknown), Siobhán Glavey, Mary T. Keogan, (unknown)	3
9	The Molecular Epidemiology of Resistance in Cefotaximase-Producing Escherichia coli Clinical Isolates from Dublin, Ireland 2016 ·Microbial Drug Resistance ·Liam P. Burke, H. Humphreys, Deirdre Fitzgerald‐Hughes	10
10	Low predictive value of positive transplant perfusion fluid cultures for diagnosing postoperative infections in kidney and kidney–pancreas transplantation 2012 ·Journal of Clinical Pathology ·(unknown), Elizabeth Smyth, Joanne O’Gorman, Sarah Browne, David P. Hickey, H. Humphreys	7
11	Undergraduate and postgraduate medical education on the prevention and control of healthcare-associated infection. More progress is needed 2011 ·International journal of infection control ·H. Humphreys, (unknown)	4
12	Use of e-learning to enhance medical students’ understanding and knowledge of healthcare-associated infection prevention and control 2011 ·Journal of Hospital Infection ·Eoghan O’Neill, Niall T. Stevens, Eric Clarke, (unknown), Bert W. O’Malley, H. Humphreys	29
13	A 12-year review of Staphylococcus aureus bloodstream infections in haemodialysis patients: more work to be done 2011 ·Journal of Hospital Infection ·(unknown), Joanne O’Gorman, M. Morris-Downes, Rachel Crowley, (unknown), Raazi Bajwa, E.G. Smyth, Fidelma Fitzpatrick, Peter J. Conlon, H. Humphreys	33
14	MRSA screening: can one swab be used for both culture and rapid testing? An evaluation of chromogenic culture and subsequent Hain GenoQuick PCR amplification/detection 2009 ·Clinical Microbiology and Infection ·Orla Sherlock, Anthony Dolan, H. Humphreys	9
15	Prevention and control of methicillin-resistant Staphylococcus aureus 2009 ·Clinical Microbiology and Infection ·H. Humphreys, Hajo Grundmann, Robert Skov, (unknown), Roberto Cauda	36
16	Monitoring infective complications following hip fracture 1998 ·Journal of Hospital Infection ·J.E. Enstone, H. Humphreys	11
17	Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs 1997 ·Gut ·(unknown), (unknown), David Greenwood, H. Humphreys, (unknown), Richard F. Logan, Christopher J. Hawkey	106
18	Hemofiltration: treating and preventing infection 1996 ·Clinical Microbiology and Infection ·(unknown), H. Humphreys	6
19	A controlled trial of selective decontamination of the digestive tract in intensive care and its effect on nosocomial infection 1992 ·Journal of Antimicrobial Chemotherapy ·Robbert J. de Winter, H. Humphreys, (unknown), Alasdair MacGowan, Sheila M. Willatts, D. C. E. Speller	71
20	Effect of treatment on Campylobacter pylori in peptic disease: a randomised prospective trial. 1988 ·Gut ·H. Humphreys, Stephen C Bourke, Cornelius P. Dooley, D. J. McKenna, Brian Power, C. T. Keane, E. C. Sweeney, Colm O’Morain	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact